IRX Therapeutics Appoints Luba Greenwood to Board of Directors

08:00 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
IRX Therapeutics, Inc. (IRX) today announced the appointment of Luba Greenwood, Vice President of Global Business Development and Mergers & Acquisitions at F. Hoffmann-La Roche, Diagnostics, to its Board of Directors. ...

Other Sources for this Article

Media Inquiries
MacDougall Biomedical Communications
Rob Kloppenburg or Kara Mazey, 781-235-3060


More From BioPortfolio on "IRX Therapeutics Appoints Luba Greenwood to Board of Directors"

Quick Search


Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...